Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xeal Pharma is a UK-based pharmaceutical company specializing in the manufacture and distribution of bespoke unlicensed medicines, commonly referred to as "Specials." The company focuses on providing precisely formulated treatments for patients and animals with unique clinical needs that cannot be met by mass-produced medications. A significant portion of their portfolio includes cannabis-based products for medicinal use (CBPMs), which are manufactured using industry-leading process automation technologies. Xeal Pharma operates with a mission to deliver high-quality, precise medicines with speed and efficiency to healthcare providers globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xeal Diagnostics.